๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Plaque Psoriasis

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis NCT06842199Phase 346 sites๐Ÿ“ Hefei๐Ÿ“ Wuhu๐Ÿ“ Beijing Beijing InnoCare Pharma Tech Co., Ltd. ยท Tests: ICP-488 Tablets, ICP-488 Placebo A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis NCT07724366Phase 345 sites๐Ÿ“ Beijing๐Ÿ“ Chongqing๐Ÿ“ Chongqing Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharโ€ฆ ยท Tests: TQH3906 capsules, Deucravacitinib tablets 6 mg, TQH3906 Capsules placebo, Deucravacitinib tablets placebo A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD NCT07683065n/a7 sites๐Ÿ“ Badalona๐Ÿ“ Barcelona๐Ÿ“ Barcelona Novartis Pharmaceuticals Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis NCT04036188EARLY Phase 11 site๐Ÿ“ Fairborn Wright State University ยท Tests: Triamcinolone, Vitamin D3, Placebo A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) NCT06029257n/a1 site๐Ÿ“ Graz Almirall, S.A. ยท Tests: Tildrakizumab Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis NCT06696417n/a1 site๐Ÿ“ Shenyang First Hospital of China Medical University ยท Tests: Drug group๏ผšvunakizumab (IL-17A inhibitor) Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23) NCT06792487n/a1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: skin biopsy A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovioยฎ (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis NCT07663331Phase 41 site๐Ÿ“ Tianjin Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: TyboWeยฎ Adalimumab Injection SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495n/a8 sites๐Ÿ“ Nijmegen๐Ÿ“ Maastricht๐Ÿ“ Amsterdam Leiden University Medical Center Serum Substance P, Neuropathic Pain, and Central Sensitization Across Treatment Groups in Chronic Plaque Psoriasis NCT07844772n/a1 site๐Ÿ“ Istanbul Istanbul Training and Research Hospital ยท Tests: IL-17 Inhibitor Therapy, Conventional Systemic Therapy A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period NCT07733089Phase 11 site๐Ÿ“ Leiden Zealand Pharma ยท Tests: ZP9830, Placebo A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis NCT06912165Phase 21 site๐Ÿ“ Nanjing Zhejiang Wenda Pharma Technology LTD. ยท Tests: WD-890 tablet, WD-890 tablet, WD-890 tablet, Placebo Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) NCT07116967Phase 3411 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Phoenix Bristol-Myers Squibb ยท Tests: Deucravacitinib, Ustekinumab A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania NCT07582783n/a20 sites๐Ÿ“ Bรขrlad๐Ÿ“ Brasov๐Ÿ“ Bucharest Janssen Research & Development, LLC A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase โ…ข Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis NCT07672561Phase 31 site๐Ÿ“ Nanjing Zhejiang Wenda Pharma Technology LTD. ยท Tests: Drug:WD-890, Drug: placebo To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital NCT07337434EARLY Phase 11 site๐Ÿ“ Peshawar Syeda Sana Zaman ยท Tests: Methotrexate, Apremilast A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelxยฎ (Bimekizumab) NCT06888193Phase 114 sites๐Ÿ“ Santa Monica๐Ÿ“ South Miami๐Ÿ“ Boston UCB Biopharma SRL ยท Tests: Bimekizumab Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers NCT05994976n/a1 site๐Ÿ“ Montreal Innovaderm Research Inc. ยท Tests: Blood samples collection, Oral samples collection, Hair samples collection, Skin samples collection (skin tape strip anโ€ฆ A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis NCT07038720Phase 11 site๐Ÿ“ Hangzhou Usynova Pharmaceuticals Ltd. ยท Tests: UA026, Placebo Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis NCT07261306EARLY Phase 11 site๐Ÿ“ Lahore Lahore General Hospital ยท Tests: Methotrexate, Tofacitinib A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis NCT07780929NA1 site๐Ÿ“ Xi'an Xijing Hospital ยท Tests: XJH05 ointment, Calcipotriol ointment A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults NCT07233291Phase 21 site๐Ÿ“ Al Mansurah Ahmed Ibrahim ยท Tests: Oral roflumilast ROLL'YN-UST: an Observational Study in Patients Treated by Steqeymaยฎ, an Ustekinumab Biosimilar NCT06997055n/a1 site๐Ÿ“ Amiens Celltrion HealthCare France ยท Tests: Ustekinumab 45 mg, Ustekinumab 90 mg A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis NCT06030076n/a1 site๐Ÿ“ Graz Almirall, S.A. ยท Tests: Tildrakizumab Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis NCT07251998Phase 21 site๐Ÿ“ Shanghai Beijing InnoCare Pharma Tech Co., Ltd. ยท Tests: ICP-332 Tablets, ICP-332 Tablets, ICP-332 Tablets, ICP-332 Placebo Tablets A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis NCT07326813Phase 31 site๐Ÿ“ Shanghai InventisBio Co., Ltd ยท Tests: D-2570 Tablet, BMS-986165 Tablet, Placebo Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis NCT07362017Phase 310 sites๐Ÿ“ Glendale๐Ÿ“ Fremont๐Ÿ“ Miami Vanda Pharmaceuticals ยท Tests: Ponesimod A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis NCT05744466n/a1 site๐Ÿ“ Waltham Bristol-Myers Squibb ยท Tests: Deucravacitinib, Apremilast ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. NCT04347473Phase 41 site๐Ÿ“ East Windsor Psoriasis Treatment Center of Central New Jersey ยท Tests: Ilumya Injectable Product A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis NCT06979453Phase 3132 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Phoenix Bristol-Myers Squibb ยท Tests: Deucravacitinib, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy